Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly-Anne Phillips

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2015
Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family RegistryGillian S Dite, Robert J MacInnis, Adrian Bickerstaffe, et al.
Human Reproduction (Oxford, England)|April 21, 2016
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutationsKelly-Anne Phillips, Ian M Collins, Roger L Milne, et al.
JMIR Formative Research|January 27, 2019
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability TestingLouisa L Lo, Ian M Collins, Mathias Bressel, et al.
JNCI Cancer Spectrum|February 8, 2021
Motivators of Inappropriate Ovarian Cancer Screening: A Survey of Women and Their CliniciansCourtney Macdonald, Danielle Mazza, Martha Hickey, et al.
Breast Cancer Research and Treatment|February 25, 2016
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and managementIan M Collins, Adrian Bickerstaffe, Thilina Ranaweera, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 29, 2020
Breast Cancer Chemoprevention: Use and Views of Australian Women and Their CliniciansCourtney Macdonald, Christobel M Saunders, Louise A Keogh, et al.
Breast Cancer Research and Treatment|April 23, 2010
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyLori J Pierce, Kelly-Anne Phillips, Kent A Griffith, et al.
BMC Cancer|May 19, 2023
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survivalElena A Takano, Melissa M Younes, Katie Meehan, et al.
British Journal of Cancer|February 18, 2021
Survival from breast cancer in women with a BRCA2 mutation by treatmentD Gareth Evans, Kelly-Anne Phillips, Roger L Milne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2011
Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort studyPamela J Goodwin, Kelly-Anne Phillips, Dee W West, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2015
Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family RegistryGillian S Dite, Robert J MacInnis, Adrian Bickerstaffe, et al.
Human Reproduction (Oxford, England)|April 21, 2016
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutationsKelly-Anne Phillips, Ian M Collins, Roger L Milne, et al.
JMIR Formative Research|January 27, 2019
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability TestingLouisa L Lo, Ian M Collins, Mathias Bressel, et al.
JNCI Cancer Spectrum|February 8, 2021
Motivators of Inappropriate Ovarian Cancer Screening: A Survey of Women and Their CliniciansCourtney Macdonald, Danielle Mazza, Martha Hickey, et al.
Breast Cancer Research and Treatment|February 25, 2016
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and managementIan M Collins, Adrian Bickerstaffe, Thilina Ranaweera, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 29, 2020
Breast Cancer Chemoprevention: Use and Views of Australian Women and Their CliniciansCourtney Macdonald, Christobel M Saunders, Louise A Keogh, et al.
Breast Cancer Research and Treatment|April 23, 2010
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyLori J Pierce, Kelly-Anne Phillips, Kent A Griffith, et al.
BMC Cancer|May 19, 2023
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survivalElena A Takano, Melissa M Younes, Katie Meehan, et al.
British Journal of Cancer|February 18, 2021
Survival from breast cancer in women with a BRCA2 mutation by treatmentD Gareth Evans, Kelly-Anne Phillips, Roger L Milne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2011
Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort studyPamela J Goodwin, Kelly-Anne Phillips, Dee W West, et al.
Pageof 15